#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0368] It is thought that, although absolute surface area is increased on substrates growing nanofibers, the low solid surface volume, lack of continuity and nanoscale aspect of the fibers discourages cellular attachment.
1-1	0-1	[	_	_	
1-2	1-5	0368	_	_	
1-3	5-6	]	_	_	
1-4	7-9	It	_	_	
1-5	10-12	is	_	_	
1-6	13-20	thought	_	_	
1-7	21-25	that	_	_	
1-8	25-26	,	_	_	
1-9	27-35	although	_	_	
1-10	36-44	absolute	_	_	
1-11	45-52	surface	_	_	
1-12	53-57	area	_	_	
1-13	58-60	is	_	_	
1-14	61-70	increased	_	_	
1-15	71-73	on	_	_	
1-16	74-84	substrates	_	_	
1-17	85-92	growing	_	_	
1-18	93-103	nanofibers	_	_	
1-19	103-104	,	_	_	
1-20	105-108	the	_	_	
1-21	109-112	low	_	_	
1-22	113-118	solid	_	_	
1-23	119-126	surface	_	_	
1-24	127-133	volume	_	_	
1-25	133-134	,	_	_	
1-26	135-139	lack	_	_	
1-27	140-142	of	_	_	
1-28	143-153	continuity	_	_	
1-29	154-157	and	_	_	
1-30	158-167	nanoscale	_	_	
1-31	168-174	aspect	_	_	
1-32	175-177	of	_	_	
1-33	178-181	the	_	_	
1-34	182-188	fibers	_	_	
1-35	189-200	discourages	_	_	
1-36	201-209	cellular	_	_	
1-37	210-220	attachment	_	_	
1-38	220-221	.	_	_	

#Text=The nanowire surfaces used in these illustrations herein was produced for an electronics application and was not optimized for this use, yet, as will be noted, such surfaces still reduced biofilm accumulation.
2-1	222-225	The	_	_	
2-2	226-234	nanowire	_	_	
2-3	235-243	surfaces	_	_	
2-4	244-248	used	_	_	
2-5	249-251	in	_	_	
2-6	252-257	these	_	_	
2-7	258-271	illustrations	_	_	
2-8	272-278	herein	_	_	
2-9	279-282	was	_	_	
2-10	283-291	produced	_	_	
2-11	292-295	for	_	_	
2-12	296-298	an	_	_	
2-13	299-310	electronics	_	_	
2-14	311-322	application	_	_	
2-15	323-326	and	_	_	
2-16	327-330	was	_	_	
2-17	331-334	not	_	_	
2-18	335-344	optimized	_	_	
2-19	345-348	for	_	_	
2-20	349-353	this	_	_	
2-21	354-357	use	_	_	
2-22	357-358	,	_	_	
2-23	359-362	yet	_	_	
2-24	362-363	,	_	_	
2-25	364-366	as	_	_	
2-26	367-371	will	_	_	
2-27	372-374	be	_	_	
2-28	375-380	noted	_	_	
2-29	380-381	,	_	_	
2-30	382-386	such	_	_	
2-31	387-395	surfaces	_	_	
2-32	396-401	still	_	_	
2-33	402-409	reduced	_	_	
2-34	410-417	biofilm	_	_	
2-35	418-430	accumulation	_	_	
2-36	430-431	.	_	_	

#Text=The silicon wires utilized were .about.40 nm in diameter and 50 to 100 um in length and were grown on a four inch silicon substrate.
3-1	432-435	The	_	_	
3-2	436-443	silicon	_	_	
3-3	444-449	wires	_	_	
3-4	450-458	utilized	_	_	
3-5	459-463	were	_	_	
3-6	464-465	.	_	_	
3-7	465-470	about	_	_	
3-8	470-473	.40	_	_	
3-9	474-476	nm	_	_	
3-10	477-479	in	_	_	
3-11	480-488	diameter	_	_	
3-12	489-492	and	_	_	
3-13	493-495	50	_	_	
3-14	496-498	to	_	_	
3-15	499-502	100	_	_	
3-16	503-505	um	_	_	
3-17	506-508	in	_	_	
3-18	509-515	length	_	_	
3-19	516-519	and	_	_	
3-20	520-524	were	_	_	
3-21	525-530	grown	_	_	
3-22	531-533	on	_	_	
3-23	534-535	a	_	_	
3-24	536-540	four	_	_	
3-25	541-545	inch	_	_	
3-26	546-553	silicon	_	_	
3-27	554-563	substrate	_	_	
3-28	563-564	.	_	_	

#Text=The nanowire preparation method is described below.
4-1	565-568	The	_	_	
4-2	569-577	nanowire	_	_	
4-3	578-589	preparation	_	_	
4-4	590-596	method	_	_	
4-5	597-599	is	_	_	
4-6	600-609	described	_	_	
4-7	610-615	below	_	_	
4-8	615-616	.	_	_	

#Text=In the current example, the nanowire pieces used in this experiment were about 0.25 cm.sup.2.
5-1	617-619	In	_	_	
5-2	620-623	the	_	_	
5-3	624-631	current	_	_	
5-4	632-639	example	_	_	
5-5	639-640	,	_	_	
5-6	641-644	the	_	_	
5-7	645-653	nanowire	_	_	
5-8	654-660	pieces	_	_	
5-9	661-665	used	_	_	
5-10	666-668	in	_	_	
5-11	669-673	this	_	_	
5-12	674-684	experiment	_	_	
5-13	685-689	were	_	_	
5-14	690-695	about	_	_	
5-15	696-700	0.25	_	_	
5-16	701-707	cm.sup	_	_	
5-17	707-709	.2	_	_	
5-18	709-710	.	_	_	

#Text=Immediately before introduction into the culture media they were soaked in 100% ethanol and blown dry with a stream of nitrogen.
6-1	711-722	Immediately	_	_	
6-2	723-729	before	_	_	
6-3	730-742	introduction	_	_	
6-4	743-747	into	_	_	
6-5	748-751	the	_	_	
6-6	752-759	culture	_	_	
6-7	760-765	media	_	_	
6-8	766-770	they	_	_	
6-9	771-775	were	_	_	
6-10	776-782	soaked	_	_	
6-11	783-785	in	_	_	
6-12	786-790	100%	_	_	
6-13	791-798	ethanol	_	_	
6-14	799-802	and	_	_	
6-15	803-808	blown	_	_	
6-16	809-812	dry	_	_	
6-17	813-817	with	_	_	
6-18	818-819	a	_	_	
6-19	820-826	stream	_	_	
6-20	827-829	of	_	_	
6-21	830-838	nitrogen	_	_	
6-22	838-839	.	_	_	

#Text=Silicon wafer controls (i.e., without nanowires) were also soaked in ethanol and blown dry.
7-1	840-847	Silicon	_	_	
7-2	848-853	wafer	_	_	
7-3	854-862	controls	_	_	
7-4	863-864	(	_	_	
7-5	864-867	i.e	_	_	
7-6	867-868	.	_	_	
7-7	868-869	,	_	_	
7-8	870-877	without	_	_	
7-9	878-887	nanowires	_	_	
7-10	887-888	)	_	_	
7-11	889-893	were	_	_	
7-12	894-898	also	_	_	
7-13	899-905	soaked	_	_	
7-14	906-908	in	_	_	
7-15	909-916	ethanol	_	_	
7-16	917-920	and	_	_	
7-17	921-926	blown	_	_	
7-18	927-930	dry	_	_	
7-19	930-931	.	_	_	

#Text=S. epidermidis was grown in LB broth for 6 hours at 37.degree.
8-1	932-933	S	_	_	
8-2	933-934	.	_	_	
8-3	935-946	epidermidis	_	_	
8-4	947-950	was	_	_	
8-5	951-956	grown	_	_	
8-6	957-959	in	_	_	
8-7	960-962	LB	_	_	
8-8	963-968	broth	_	_	
8-9	969-972	for	_	_	
8-10	973-974	6	_	_	
8-11	975-980	hours	_	_	
8-12	981-983	at	_	_	
8-13	984-986	37	_	_	
8-14	986-987	.	_	_	
8-15	987-993	degree	_	_	
8-16	993-994	.	_	_	

#Text=C. with gentle shaking in 35 mm Petri dishes.
9-1	995-996	C	_	_	
9-2	996-997	.	_	_	
9-3	998-1002	with	_	_	
9-4	1003-1009	gentle	_	_	
9-5	1010-1017	shaking	_	_	
9-6	1018-1020	in	_	_	
9-7	1021-1023	35	_	_	
9-8	1024-1026	mm	_	_	
9-9	1027-1032	Petri	_	_	
9-10	1033-1039	dishes	_	_	
9-11	1039-1040	.	_	_	

#Text=Wafer sections were then placed in the culture and left for 24 hours at 37.degree.
10-1	1041-1046	Wafer	_	_	
10-2	1047-1055	sections	_	_	
10-3	1056-1060	were	_	_	
10-4	1061-1065	then	_	_	
10-5	1066-1072	placed	_	_	
10-6	1073-1075	in	_	_	
10-7	1076-1079	the	_	_	
10-8	1080-1087	culture	_	_	
10-9	1088-1091	and	_	_	
10-10	1092-1096	left	_	_	
10-11	1097-1100	for	_	_	
10-12	1101-1103	24	_	_	
10-13	1104-1109	hours	_	_	
10-14	1110-1112	at	_	_	
10-15	1113-1115	37	_	_	
10-16	1115-1116	.	_	_	
10-17	1116-1122	degree	_	_	
10-18	1122-1123	.	_	_	

#Text=C. in the original media.
11-1	1124-1125	C	_	_	
11-2	1125-1126	.	_	_	
11-3	1127-1129	in	_	_	
11-4	1130-1133	the	_	_	
11-5	1134-1142	original	_	_	
11-6	1143-1148	media	_	_	
11-7	1148-1149	.	_	_	

#Text=The wafer slices were removed after 24 hours incubation, washed briefly in fresh media, rapidly immersed in water and then heat fixed for 30 seconds prior to staining in a 0.2% crystal violet solution.
12-1	1150-1153	The	_	_	
12-2	1154-1159	wafer	_	_	
12-3	1160-1166	slices	_	_	
12-4	1167-1171	were	_	_	
12-5	1172-1179	removed	_	_	
12-6	1180-1185	after	_	_	
12-7	1186-1188	24	_	_	
12-8	1189-1194	hours	_	_	
12-9	1195-1205	incubation	_	_	
12-10	1205-1206	,	_	_	
12-11	1207-1213	washed	_	_	
12-12	1214-1221	briefly	_	_	
12-13	1222-1224	in	_	_	
12-14	1225-1230	fresh	_	_	
12-15	1231-1236	media	_	_	
12-16	1236-1237	,	_	_	
12-17	1238-1245	rapidly	_	_	
12-18	1246-1254	immersed	_	_	
12-19	1255-1257	in	_	_	
12-20	1258-1263	water	_	_	
12-21	1264-1267	and	_	_	
12-22	1268-1272	then	_	_	
12-23	1273-1277	heat	_	_	
12-24	1278-1283	fixed	_	_	
12-25	1284-1287	for	_	_	
12-26	1288-1290	30	_	_	
12-27	1291-1298	seconds	_	_	
12-28	1299-1304	prior	_	_	
12-29	1305-1307	to	_	_	
12-30	1308-1316	staining	_	_	
12-31	1317-1319	in	_	_	
12-32	1320-1321	a	_	_	
12-33	1322-1326	0.2%	_	_	
12-34	1327-1334	crystal	_	_	
12-35	1335-1341	violet	_	_	
12-36	1342-1350	solution	_	_	
12-37	1350-1351	.	_	_	

#Text=The wafer segments were rinsed thoroughly in water.
13-1	1352-1355	The	_	_	
13-2	1356-1361	wafer	_	_	
13-3	1362-1370	segments	_	_	
13-4	1371-1375	were	_	_	
13-5	1376-1382	rinsed	_	_	
13-6	1383-1393	thoroughly	_	_	
13-7	1394-1396	in	_	_	
13-8	1397-1402	water	_	_	
13-9	1402-1403	.	_	_	

#Text=Any microbes attached to the wafers were visualized by conventional brightfield microscopy.
14-1	1404-1407	Any	_	_	
14-2	1408-1416	microbes	_	_	
14-3	1417-1425	attached	_	_	
14-4	1426-1428	to	_	_	
14-5	1429-1432	the	_	_	
14-6	1433-1439	wafers	_	_	
14-7	1440-1444	were	_	_	
14-8	1445-1455	visualized	_	_	
14-9	1456-1458	by	_	_	
14-10	1459-1471	conventional	_	_	
14-11	1472-1483	brightfield	_	_	
14-12	1484-1494	microscopy	_	_	
14-13	1494-1495	.	_	_	

#Text=Images were captured with a digital camera.
15-1	1496-1502	Images	_	_	
15-2	1503-1507	were	_	_	
15-3	1508-1516	captured	_	_	
15-4	1517-1521	with	_	_	
15-5	1522-1523	a	_	_	
15-6	1524-1531	digital	_	_	
15-7	1532-1538	camera	_	_	
15-8	1538-1539	.	_	_	

#Text=The results showed approximately a ten fold decrease in bacteria on the nanowire substrate as compared to the silicon wafer control.
16-1	1540-1543	The	_	_	
16-2	1544-1551	results	_	_	
16-3	1552-1558	showed	_	_	
16-4	1559-1572	approximately	_	_	
16-5	1573-1574	a	_	_	
16-6	1575-1578	ten	_	_	
16-7	1579-1583	fold	_	_	
16-8	1584-1592	decrease	_	_	
16-9	1593-1595	in	_	_	
16-10	1596-1604	bacteria	_	_	
16-11	1605-1607	on	_	_	
16-12	1608-1611	the	_	_	
16-13	1612-1620	nanowire	_	_	
16-14	1621-1630	substrate	_	_	
16-15	1631-1633	as	_	_	
16-16	1634-1642	compared	_	_	
16-17	1643-1645	to	_	_	
16-18	1646-1649	the	_	_	
16-19	1650-1657	silicon	_	_	
16-20	1658-1663	wafer	_	_	
16-21	1664-1671	control	_	_	
16-22	1671-1672	.	_	_	

#Text=Quantitation was performed on the microscope by focusing through the nanowires since the thickness of the nanowire layer was greater than the depth of field of the microscope.
#Text=[0369] To illustrate the nanofiber surfaces' repulsion of mammalian cells, CHO cells were maintained in culture in complete media (Hams F12 media supplemented with 10% fetal bovine serum) at 37.degree.
17-1	1673-1685	Quantitation	_	_	
17-2	1686-1689	was	_	_	
17-3	1690-1699	performed	_	_	
17-4	1700-1702	on	_	_	
17-5	1703-1706	the	_	_	
17-6	1707-1717	microscope	_	_	
17-7	1718-1720	by	_	_	
17-8	1721-1729	focusing	_	_	
17-9	1730-1737	through	_	_	
17-10	1738-1741	the	_	_	
17-11	1742-1751	nanowires	_	_	
17-12	1752-1757	since	_	_	
17-13	1758-1761	the	_	_	
17-14	1762-1771	thickness	_	_	
17-15	1772-1774	of	_	_	
17-16	1775-1778	the	_	_	
17-17	1779-1787	nanowire	_	_	
17-18	1788-1793	layer	_	_	
17-19	1794-1797	was	_	_	
17-20	1798-1805	greater	_	_	
17-21	1806-1810	than	_	_	
17-22	1811-1814	the	_	_	
17-23	1815-1820	depth	_	_	
17-24	1821-1823	of	_	_	
17-25	1824-1829	field	_	_	
17-26	1830-1832	of	_	_	
17-27	1833-1836	the	_	_	
17-28	1837-1847	microscope	_	_	
17-29	1847-1848	.	_	_	
17-30	1849-1850	[	_	_	
17-31	1850-1854	0369	_	_	
17-32	1854-1855	]	_	_	
17-33	1856-1858	To	_	_	
17-34	1859-1869	illustrate	_	_	
17-35	1870-1873	the	_	_	
17-36	1874-1883	nanofiber	_	_	
17-37	1884-1892	surfaces	_	_	
17-38	1892-1893	'	_	_	
17-39	1894-1903	repulsion	_	_	
17-40	1904-1906	of	_	_	
17-41	1907-1916	mammalian	_	_	
17-42	1917-1922	cells	_	_	
17-43	1922-1923	,	_	_	
17-44	1924-1927	CHO	_	_	
17-45	1928-1933	cells	_	_	
17-46	1934-1938	were	_	_	
17-47	1939-1949	maintained	_	_	
17-48	1950-1952	in	_	_	
17-49	1953-1960	culture	_	_	
17-50	1961-1963	in	_	_	
17-51	1964-1972	complete	_	_	
17-52	1973-1978	media	_	_	
17-53	1979-1980	(	_	_	
17-54	1980-1984	Hams	_	_	
17-55	1985-1988	F12	_	_	
17-56	1989-1994	media	_	_	
17-57	1995-2007	supplemented	_	_	
17-58	2008-2012	with	_	_	
17-59	2013-2016	10%	_	_	
17-60	2017-2022	fetal	_	_	
17-61	2023-2029	bovine	_	_	
17-62	2030-2035	serum	_	_	
17-63	2035-2036	)	_	_	
17-64	2037-2039	at	_	_	
17-65	2040-2042	37	_	_	
17-66	2042-2043	.	_	_	
17-67	2043-2049	degree	_	_	
17-68	2049-2050	.	_	_	

#Text=C. in a 5% CO.sub.2 atmosphere.
18-1	2051-2052	C	_	_	
18-2	2052-2053	.	_	_	
18-3	2054-2056	in	_	_	
18-4	2057-2058	a	_	_	
18-5	2059-2061	5%	_	_	
18-6	2062-2068	CO.sub	_	_	
18-7	2068-2070	.2	_	_	
18-8	2071-2081	atmosphere	_	_	
18-9	2081-2082	.	_	_	

#Text=Wafer segments were placed in 35 mm cell culture treated Petri dishes.
19-1	2083-2088	Wafer	_	_	
19-2	2089-2097	segments	_	_	
19-3	2098-2102	were	_	_	
19-4	2103-2109	placed	_	_	
19-5	2110-2112	in	_	_	
19-6	2113-2115	35	_	_	
19-7	2116-2118	mm	_	_	
19-8	2119-2123	cell	_	_	
19-9	2124-2131	culture	_	_	
19-10	2132-2139	treated	_	_	
19-11	2140-2145	Petri	_	_	
19-12	2146-2152	dishes	_	_	
19-13	2152-2153	.	_	_	

#Text=CHO cells were seeded into the dishes at a density of 10.sup.6 cell/ml in complete media after trypsinization from confluent culture.
20-1	2154-2157	CHO	_	_	
20-2	2158-2163	cells	_	_	
20-3	2164-2168	were	_	_	
20-4	2169-2175	seeded	_	_	
20-5	2176-2180	into	_	_	
20-6	2181-2184	the	_	_	
20-7	2185-2191	dishes	_	_	
20-8	2192-2194	at	_	_	
20-9	2195-2196	a	_	_	
20-10	2197-2204	density	_	_	
20-11	2205-2207	of	_	_	
20-12	2208-2210	10	_	_	
20-13	2210-2211	.	_	_	
20-14	2211-2214	sup	_	_	
20-15	2214-2216	.6	_	_	
20-16	2217-2221	cell	_	_	
20-17	2221-2222	/	_	_	
20-18	2222-2224	ml	_	_	
20-19	2225-2227	in	_	_	
20-20	2228-2236	complete	_	_	
20-21	2237-2242	media	_	_	
20-22	2243-2248	after	_	_	
20-23	2249-2263	trypsinization	_	_	
20-24	2264-2268	from	_	_	
20-25	2269-2278	confluent	_	_	
20-26	2279-2286	culture	_	_	
20-27	2286-2287	.	_	_	

#Text=The cells were allowed to adhere overnight and were then observed microscopically every 24 hours.
21-1	2288-2291	The	_	_	
21-2	2292-2297	cells	_	_	
21-3	2298-2302	were	_	_	
21-4	2303-2310	allowed	_	_	
21-5	2311-2313	to	_	_	
21-6	2314-2320	adhere	_	_	
21-7	2321-2330	overnight	_	_	
21-8	2331-2334	and	_	_	
21-9	2335-2339	were	_	_	
21-10	2340-2344	then	_	_	
21-11	2345-2353	observed	_	_	
21-12	2354-2369	microscopically	_	_	
21-13	2370-2375	every	_	_	
21-14	2376-2378	24	_	_	
21-15	2379-2384	hours	_	_	
21-16	2384-2385	.	_	_	

#Text=The surface of the 35 mm Petri dish was confluent at 48 hours when the first observation was made.
22-1	2386-2389	The	_	_	
22-2	2390-2397	surface	_	_	
22-3	2398-2400	of	_	_	
22-4	2401-2404	the	_	_	
22-5	2405-2407	35	_	_	
22-6	2408-2410	mm	_	_	
22-7	2411-2416	Petri	_	_	
22-8	2417-2421	dish	_	_	
22-9	2422-2425	was	_	_	
22-10	2426-2435	confluent	_	_	
22-11	2436-2438	at	_	_	
22-12	2439-2441	48	_	_	
22-13	2442-2447	hours	_	_	
22-14	2448-2452	when	_	_	
22-15	2453-2456	the	_	_	
22-16	2457-2462	first	_	_	
22-17	2463-2474	observation	_	_	
22-18	2475-2478	was	_	_	
22-19	2479-2483	made	_	_	
22-20	2483-2484	.	_	_	

#Text=No cell growth was observed directly on the nanowire surface.
23-1	2485-2487	No	_	_	
23-2	2488-2492	cell	_	_	
23-3	2493-2499	growth	_	_	
23-4	2500-2503	was	_	_	
23-5	2504-2512	observed	_	_	
23-6	2513-2521	directly	_	_	
23-7	2522-2524	on	_	_	
23-8	2525-2528	the	_	_	
23-9	2529-2537	nanowire	_	_	
23-10	2538-2545	surface	_	_	
23-11	2545-2546	.	_	_	

#Text=Where the nanowires had been removed by scratching the surface with a knife the cells adhered and grew.
24-1	2547-2552	Where	_	_	
24-2	2553-2556	the	_	_	
24-3	2557-2566	nanowires	_	_	
24-4	2567-2570	had	_	_	
24-5	2571-2575	been	_	_	
24-6	2576-2583	removed	_	_	
24-7	2584-2586	by	_	_	
24-8	2587-2597	scratching	_	_	
24-9	2598-2601	the	_	_	
24-10	2602-2609	surface	_	_	
24-11	2610-2614	with	_	_	
24-12	2615-2616	a	_	_	
24-13	2617-2622	knife	_	_	
24-14	2623-2626	the	_	_	
24-15	2627-2632	cells	_	_	
24-16	2633-2640	adhered	_	_	
24-17	2641-2644	and	_	_	
24-18	2645-2649	grew	_	_	
24-19	2649-2650	.	_	_	

#Text=Silicon wafer controls became confluent with cells.
25-1	2651-2658	Silicon	_	_	
25-2	2659-2664	wafer	_	_	
25-3	2665-2673	controls	_	_	
25-4	2674-2680	became	_	_	
25-5	2681-2690	confluent	_	_	
25-6	2691-2695	with	_	_	
25-7	2696-2701	cells	_	_	
25-8	2701-2702	.	_	_	

#Text=In these experiments complete retardation of mammalian cellular growth and approximately a 10.times. reduction in bacterial growth was observed.
26-1	2703-2705	In	_	_	
26-2	2706-2711	these	_	_	
26-3	2712-2723	experiments	_	_	
26-4	2724-2732	complete	_	_	
26-5	2733-2744	retardation	_	_	
26-6	2745-2747	of	_	_	
26-7	2748-2757	mammalian	_	_	
26-8	2758-2766	cellular	_	_	
26-9	2767-2773	growth	_	_	
26-10	2774-2777	and	_	_	
26-11	2778-2791	approximately	_	_	
26-12	2792-2793	a	_	_	
26-13	2794-2796	10	_	_	
26-14	2796-2797	.	_	_	
26-15	2797-2802	times	_	_	
26-16	2802-2803	.	_	_	
26-17	2804-2813	reduction	_	_	
26-18	2814-2816	in	_	_	
26-19	2817-2826	bacterial	_	_	
26-20	2827-2833	growth	_	_	
26-21	2834-2837	was	_	_	
26-22	2838-2846	observed	_	_	
26-23	2846-2847	.	_	_	

#Text=The control surfaces were chemically identical to the nanowires so it is thought that reduction in cell and bacterial growth is due to the unique surface morphology of the nanofiber enhanced surface area substrates.
#Text=[0370] S. epidermidis was used in the illustrations herein because it is a representative bacteria involved in infections of medical devices.
27-1	2848-2851	The	_	_	
27-2	2852-2859	control	_	_	
27-3	2860-2868	surfaces	_	_	
27-4	2869-2873	were	_	_	
27-5	2874-2884	chemically	_	_	
27-6	2885-2894	identical	_	_	
27-7	2895-2897	to	_	_	
27-8	2898-2901	the	_	_	
27-9	2902-2911	nanowires	_	_	
27-10	2912-2914	so	_	_	
27-11	2915-2917	it	_	_	
27-12	2918-2920	is	_	_	
27-13	2921-2928	thought	_	_	
27-14	2929-2933	that	_	_	
27-15	2934-2943	reduction	_	_	
27-16	2944-2946	in	_	_	
27-17	2947-2951	cell	_	_	
27-18	2952-2955	and	_	_	
27-19	2956-2965	bacterial	_	_	
27-20	2966-2972	growth	_	_	
27-21	2973-2975	is	_	_	
27-22	2976-2979	due	_	_	
27-23	2980-2982	to	_	_	
27-24	2983-2986	the	_	_	
27-25	2987-2993	unique	_	_	
27-26	2994-3001	surface	_	_	
27-27	3002-3012	morphology	_	_	
27-28	3013-3015	of	_	_	
27-29	3016-3019	the	_	_	
27-30	3020-3029	nanofiber	_	_	
27-31	3030-3038	enhanced	_	_	
27-32	3039-3046	surface	_	_	
27-33	3047-3051	area	_	_	
27-34	3052-3062	substrates	_	_	
27-35	3062-3063	.	_	_	
27-36	3064-3065	[	_	_	
27-37	3065-3069	0370	_	_	
27-38	3069-3070	]	_	_	
27-39	3071-3072	S	_	_	
27-40	3072-3073	.	_	_	
27-41	3074-3085	epidermidis	_	_	
27-42	3086-3089	was	_	_	
27-43	3090-3094	used	_	_	
27-44	3095-3097	in	_	_	
27-45	3098-3101	the	_	_	
27-46	3102-3115	illustrations	_	_	
27-47	3116-3122	herein	_	_	
27-48	3123-3130	because	_	_	
27-49	3131-3133	it	_	_	
27-50	3134-3136	is	_	_	
27-51	3137-3138	a	_	_	
27-52	3139-3153	representative	_	_	
27-53	3154-3162	bacteria	_	_	
27-54	3163-3171	involved	_	_	
27-55	3172-3174	in	_	_	
27-56	3175-3185	infections	_	_	
27-57	3186-3188	of	_	_	
27-58	3189-3196	medical	_	_	
27-59	3197-3204	devices	_	_	
27-60	3204-3205	.	_	_	

#Text=Additionally, S. epidermidis has been widely used in the evaluation of biomaterials and has been identified as a dominant species in biomaterial centered infections.
28-1	3206-3218	Additionally	_	_	
28-2	3218-3219	,	_	_	
28-3	3220-3221	S	_	_	
28-4	3221-3222	.	_	_	
28-5	3223-3234	epidermidis	_	_	
28-6	3235-3238	has	_	_	
28-7	3239-3243	been	_	_	
28-8	3244-3250	widely	_	_	
28-9	3251-3255	used	_	_	
28-10	3256-3258	in	_	_	
28-11	3259-3262	the	_	_	
28-12	3263-3273	evaluation	_	_	
28-13	3274-3276	of	_	_	
28-14	3277-3289	biomaterials	_	_	
28-15	3290-3293	and	_	_	
28-16	3294-3297	has	_	_	
28-17	3298-3302	been	_	_	
28-18	3303-3313	identified	_	_	
28-19	3314-3316	as	_	_	
28-20	3317-3318	a	_	_	
28-21	3319-3327	dominant	_	_	
28-22	3328-3335	species	_	_	
28-23	3336-3338	in	_	_	
28-24	3339-3350	biomaterial	_	_	
28-25	3351-3359	centered	_	_	
28-26	3360-3370	infections	_	_	
28-27	3370-3371	.	_	_	

#Text=Other bacteria implicated in biomaterial related infections such as S. aureus, Pseudomonas aeruginosa and B-hemolytic streptococci are also contemplated as being prohibited through use of current embodiments.
29-1	3372-3377	Other	_	_	
29-2	3378-3386	bacteria	_	_	
29-3	3387-3397	implicated	_	_	
29-4	3398-3400	in	_	_	
29-5	3401-3412	biomaterial	_	_	
29-6	3413-3420	related	_	_	
29-7	3421-3431	infections	_	_	
29-8	3432-3436	such	_	_	
29-9	3437-3439	as	_	_	
29-10	3440-3441	S	_	_	
29-11	3441-3442	.	_	_	
29-12	3443-3449	aureus	_	_	
29-13	3449-3450	,	_	_	
29-14	3451-3462	Pseudomonas	_	_	
29-15	3463-3473	aeruginosa	_	_	
29-16	3474-3477	and	_	_	
29-17	3478-3489	B-hemolytic	_	_	
29-18	3490-3502	streptococci	_	_	
29-19	3503-3506	are	_	_	
29-20	3507-3511	also	_	_	
29-21	3512-3524	contemplated	_	_	
29-22	3525-3527	as	_	_	
29-23	3528-3533	being	_	_	
29-24	3534-3544	prohibited	_	_	
29-25	3545-3552	through	_	_	
29-26	3553-3556	use	_	_	
29-27	3557-3559	of	_	_	
29-28	3560-3567	current	_	_	
29-29	3568-3579	embodiments	_	_	
29-30	3579-3580	.	_	_	

#Text=In addition to CHO cells illustrated herein, other common tissue culture lines such as, e.g., MDCK, L-929 and HL60 cells are also contemplated as being prohibited through use of current embodiments.
30-1	3581-3583	In	_	_	
30-2	3584-3592	addition	_	_	
30-3	3593-3595	to	_	_	
30-4	3596-3599	CHO	_	_	
30-5	3600-3605	cells	_	_	
30-6	3606-3617	illustrated	_	_	
30-7	3618-3624	herein	_	_	
30-8	3624-3625	,	_	_	
30-9	3626-3631	other	_	_	
30-10	3632-3638	common	_	_	
30-11	3639-3645	tissue	_	_	
30-12	3646-3653	culture	_	_	
30-13	3654-3659	lines	_	_	
30-14	3660-3664	such	_	_	
30-15	3665-3667	as	_	_	
30-16	3667-3668	,	_	_	
30-17	3669-3672	e.g	_	_	
30-18	3672-3673	.	_	_	
30-19	3673-3674	,	_	_	
30-20	3675-3679	MDCK	_	_	
30-21	3679-3680	,	_	_	
30-22	3681-3682	L	_	_	
30-23	3682-3683	-	_	_	
30-24	3683-3686	929	_	_	
30-25	3687-3690	and	_	_	
30-26	3691-3695	HL60	_	_	
30-27	3696-3701	cells	_	_	
30-28	3702-3705	are	_	_	
30-29	3706-3710	also	_	_	
30-30	3711-3723	contemplated	_	_	
30-31	3724-3726	as	_	_	
30-32	3727-3732	being	_	_	
30-33	3733-3743	prohibited	_	_	
30-34	3744-3751	through	_	_	
30-35	3752-3755	use	_	_	
30-36	3756-3758	of	_	_	
30-37	3759-3766	current	_	_	
30-38	3767-3778	embodiments	_	_	
30-39	3778-3779	.	_	_	

#Text=Such cell lines represent a wide diversity of cell types.
31-1	3780-3784	Such	_	_	
31-2	3785-3789	cell	_	_	
31-3	3790-3795	lines	_	_	
31-4	3796-3805	represent	_	_	
31-5	3806-3807	a	_	_	
31-6	3808-3812	wide	_	_	
31-7	3813-3822	diversity	_	_	
31-8	3823-3825	of	_	_	
31-9	3826-3830	cell	_	_	
31-10	3831-3836	types	_	_	
31-11	3836-3837	.	_	_	

#Text=The CHO and MDCK cells are representative of epithelial cells, L-929 cells participate in the formation of connective tissue and the HL60 line represents immune surveillance cells.
32-1	3838-3841	The	_	_	
32-2	3842-3845	CHO	_	_	
32-3	3846-3849	and	_	_	
32-4	3850-3854	MDCK	_	_	
32-5	3855-3860	cells	_	_	
32-6	3861-3864	are	_	_	
32-7	3865-3879	representative	_	_	
32-8	3880-3882	of	_	_	
32-9	3883-3893	epithelial	_	_	
32-10	3894-3899	cells	_	_	
32-11	3899-3900	,	_	_	
32-12	3901-3902	L	_	_	
32-13	3902-3903	-	_	_	
32-14	3903-3906	929	_	_	
32-15	3907-3912	cells	_	_	
32-16	3913-3924	participate	_	_	
32-17	3925-3927	in	_	_	
32-18	3928-3931	the	_	_	
32-19	3932-3941	formation	_	_	
32-20	3942-3944	of	_	_	
32-21	3945-3955	connective	_	_	
32-22	3956-3962	tissue	_	_	
32-23	3963-3966	and	_	_	
32-24	3967-3970	the	_	_	
32-25	3971-3975	HL60	_	_	
32-26	3976-3980	line	_	_	
32-27	3981-3991	represents	_	_	
32-28	3992-3998	immune	_	_	
32-29	3999-4011	surveillance	_	_	
32-30	4012-4017	cells	_	_	
32-31	4017-4018	.	_	_	

#Text=Thus, the nanofiber enhanced surface areas herein are contemplated against these cell types and other common in vivo cell types.
33-1	4019-4023	Thus	_	_	
33-2	4023-4024	,	_	_	
33-3	4025-4028	the	_	_	
33-4	4029-4038	nanofiber	_	_	
33-5	4039-4047	enhanced	_	_	
33-6	4048-4055	surface	_	_	
33-7	4056-4061	areas	_	_	
33-8	4062-4068	herein	_	_	
33-9	4069-4072	are	_	_	
33-10	4073-4085	contemplated	_	_	
33-11	4086-4093	against	_	_	
33-12	4094-4099	these	_	_	
33-13	4100-4104	cell	_	_	
33-14	4105-4110	types	_	_	
33-15	4111-4114	and	_	_	
33-16	4115-4120	other	_	_	
33-17	4121-4127	common	_	_	
33-18	4128-4130	in	_	_	
33-19	4131-4135	vivo	_	_	
33-20	4136-4140	cell	_	_	
33-21	4141-4146	types	_	_	
33-22	4146-4147	.	_	_	

#Text=The nanofibers used in the in vitro illustration herein were made of silicon, and, as detailed throughout, several methods have been reported in the literature for the synthesis of silicon nanowires.
34-1	4148-4151	The	*[1]	37-20[2_1]	
34-2	4152-4162	nanofibers	*[1]	_	
34-3	4163-4167	used	*[1]	_	
34-4	4168-4170	in	*[1]	_	
34-5	4171-4174	the	*[1]	_	
34-6	4175-4177	in	*[1]	_	
34-7	4178-4183	vitro	*[1]	_	
34-8	4184-4196	illustration	*[1]	_	
34-9	4197-4203	herein	*[1]	_	
34-10	4204-4208	were	*[1]	_	
34-11	4209-4213	made	*[1]	_	
34-12	4214-4216	of	*[1]	_	
34-13	4217-4224	silicon	*[1]	_	
34-14	4224-4225	,	*[1]	_	
34-15	4226-4229	and	*[1]	_	
34-16	4229-4230	,	*[1]	_	
34-17	4231-4233	as	*[1]	_	
34-18	4234-4242	detailed	*[1]	_	
34-19	4243-4253	throughout	*[1]	_	
34-20	4253-4254	,	*[1]	_	
34-21	4255-4262	several	*[1]	_	
34-22	4263-4270	methods	*[1]	_	
34-23	4271-4275	have	*[1]	_	
34-24	4276-4280	been	*[1]	_	
34-25	4281-4289	reported	*[1]	_	
34-26	4290-4292	in	*[1]	_	
34-27	4293-4296	the	*[1]	_	
34-28	4297-4307	literature	*[1]	_	
34-29	4308-4311	for	*[1]	_	
34-30	4312-4315	the	*[1]	_	
34-31	4316-4325	synthesis	*[1]	_	
34-32	4326-4328	of	*[1]	_	
34-33	4329-4336	silicon	*[1]	_	
34-34	4337-4346	nanowires	*[1]	_	
34-35	4346-4347	.	*[1]	_	

#Text=For example, laser ablating metal-containing silicon targets, high temperature vaporizing of Si/SiO.sub.2 mixture, and vapor-liquid-solid (VLS) growth using gold as the catalyst.
35-1	4348-4351	For	_	_	
35-2	4352-4359	example	_	_	
35-3	4359-4360	,	_	_	
35-4	4361-4366	laser	_	_	
35-5	4367-4375	ablating	_	_	
35-6	4376-4392	metal-containing	_	_	
35-7	4393-4400	silicon	_	_	
35-8	4401-4408	targets	_	_	
35-9	4408-4409	,	_	_	
35-10	4410-4414	high	_	_	
35-11	4415-4426	temperature	_	_	
35-12	4427-4437	vaporizing	_	_	
35-13	4438-4440	of	_	_	
35-14	4441-4443	Si	_	_	
35-15	4443-4444	/	_	_	
35-16	4444-4451	SiO.sub	_	_	
35-17	4451-4453	.2	_	_	
35-18	4454-4461	mixture	_	_	
35-19	4461-4462	,	_	_	
35-20	4463-4466	and	_	_	
35-21	4467-4485	vapor-liquid-solid	_	_	
35-22	4486-4487	(	_	_	
35-23	4487-4490	VLS	_	_	
35-24	4490-4491	)	_	_	
35-25	4492-4498	growth	_	_	
35-26	4499-4504	using	_	_	
35-27	4505-4509	gold	_	_	
35-28	4510-4512	as	_	_	
35-29	4513-4516	the	_	_	
35-30	4517-4525	catalyst	_	_	
35-31	4525-4526	.	_	_	

#Text=See, above.
36-1	4527-4530	See	_	_	
36-2	4530-4531	,	_	_	
36-3	4532-4537	above	_	_	
36-4	4537-4538	.	_	_	

#Text=While any method of construction is optionally used, the approach to nanowire synthesis is typically VLS growth since this method has been widely used for semiconductor nanowire growth.
37-1	4539-4544	While	_	_	
37-2	4545-4548	any	_	_	
37-3	4549-4555	method	_	_	
37-4	4556-4558	of	_	_	
37-5	4559-4571	construction	_	_	
37-6	4572-4574	is	_	_	
37-7	4575-4585	optionally	_	_	
37-8	4586-4590	used	_	_	
37-9	4590-4591	,	_	_	
37-10	4592-4595	the	_	_	
37-11	4596-4604	approach	_	_	
37-12	4605-4607	to	_	_	
37-13	4608-4616	nanowire	_	_	
37-14	4617-4626	synthesis	_	_	
37-15	4627-4629	is	_	_	
37-16	4630-4639	typically	_	_	
37-17	4640-4643	VLS	_	_	
37-18	4644-4650	growth	_	_	
37-19	4651-4656	since	_	_	
37-20	4657-4661	this	*[2]	_	
37-21	4662-4668	method	*[2]	_	
37-22	4669-4672	has	_	_	
37-23	4673-4677	been	_	_	
37-24	4678-4684	widely	_	_	
37-25	4685-4689	used	_	_	
37-26	4690-4693	for	_	_	
37-27	4694-4707	semiconductor	_	_	
37-28	4708-4716	nanowire	_	_	
37-29	4717-4723	growth	_	_	
37-30	4723-4724	.	_	_	

#Text=Description of such method is provided elsewhere herein.
#Text=[0371] As mentioned previously, it is thought that the primary means of biofilm prevention by nanofiber surfaces herein is due to the unique morphology of the substrate, however, it is also possible that such substrates comprise inherent cytophobicity activity.
#Text=[0372] The effect of surface hydrophilicity or hydrophobicity on growth is also optionally modified on the nanofiber substrates herein to specifically tailor biofilm prevention in different situations.
38-1	4725-4736	Description	_	_	
38-2	4737-4739	of	_	_	
38-3	4740-4744	such	_	_	
38-4	4745-4751	method	_	_	
38-5	4752-4754	is	_	_	
38-6	4755-4763	provided	_	_	
38-7	4764-4773	elsewhere	_	_	
38-8	4774-4780	herein	_	_	
38-9	4780-4781	.	_	_	
38-10	4782-4783	[	_	_	
38-11	4783-4787	0371	_	_	
38-12	4787-4788	]	_	_	
38-13	4789-4791	As	_	_	
38-14	4792-4801	mentioned	_	_	
38-15	4802-4812	previously	_	_	
38-16	4812-4813	,	_	_	
38-17	4814-4816	it	_	_	
38-18	4817-4819	is	_	_	
38-19	4820-4827	thought	_	_	
38-20	4828-4832	that	_	_	
38-21	4833-4836	the	_	_	
38-22	4837-4844	primary	_	_	
38-23	4845-4850	means	_	_	
38-24	4851-4853	of	_	_	
38-25	4854-4861	biofilm	_	_	
38-26	4862-4872	prevention	_	_	
38-27	4873-4875	by	_	_	
38-28	4876-4885	nanofiber	_	_	
38-29	4886-4894	surfaces	_	_	
38-30	4895-4901	herein	_	_	
38-31	4902-4904	is	_	_	
38-32	4905-4908	due	_	_	
38-33	4909-4911	to	_	_	
38-34	4912-4915	the	_	_	
38-35	4916-4922	unique	_	_	
38-36	4923-4933	morphology	_	_	
38-37	4934-4936	of	_	_	
38-38	4937-4940	the	_	_	
38-39	4941-4950	substrate	_	_	
38-40	4950-4951	,	_	_	
38-41	4952-4959	however	_	_	
38-42	4959-4960	,	_	_	
38-43	4961-4963	it	_	_	
38-44	4964-4966	is	_	_	
38-45	4967-4971	also	_	_	
38-46	4972-4980	possible	_	_	
38-47	4981-4985	that	_	_	
38-48	4986-4990	such	_	_	
38-49	4991-5001	substrates	_	_	
38-50	5002-5010	comprise	_	_	
38-51	5011-5019	inherent	_	_	
38-52	5020-5033	cytophobicity	_	_	
38-53	5034-5042	activity	_	_	
38-54	5042-5043	.	_	_	
38-55	5044-5045	[	_	_	
38-56	5045-5049	0372	_	_	
38-57	5049-5050	]	_	_	
38-58	5051-5054	The	_	_	
38-59	5055-5061	effect	_	_	
38-60	5062-5064	of	_	_	
38-61	5065-5072	surface	_	_	
38-62	5073-5087	hydrophilicity	_	_	
38-63	5088-5090	or	_	_	
38-64	5091-5105	hydrophobicity	_	_	
38-65	5106-5108	on	_	_	
38-66	5109-5115	growth	_	_	
38-67	5116-5118	is	_	_	
38-68	5119-5123	also	_	_	
38-69	5124-5134	optionally	_	_	
38-70	5135-5143	modified	_	_	
38-71	5144-5146	on	_	_	
38-72	5147-5150	the	_	_	
38-73	5151-5160	nanofiber	_	_	
38-74	5161-5171	substrates	_	_	
38-75	5172-5178	herein	_	_	
38-76	5179-5181	to	_	_	
38-77	5182-5194	specifically	_	_	
38-78	5195-5201	tailor	_	_	
38-79	5202-5209	biofilm	_	_	
38-80	5210-5220	prevention	_	_	
38-81	5221-5223	in	_	_	
38-82	5224-5233	different	_	_	
38-83	5234-5244	situations	_	_	
38-84	5244-5245	.	_	_	

#Text=Such functionalization goes along with variability in wire length, diameter and density on the substrate.
39-1	5246-5250	Such	_	_	
39-2	5251-5268	functionalization	_	_	
39-3	5269-5273	goes	_	_	
39-4	5274-5279	along	_	_	
39-5	5280-5284	with	_	_	
39-6	5285-5296	variability	_	_	
39-7	5297-5299	in	_	_	
39-8	5300-5304	wire	_	_	
39-9	5305-5311	length	_	_	
39-10	5311-5312	,	_	_	
39-11	5313-5321	diameter	_	_	
39-12	5322-5325	and	_	_	
39-13	5326-5333	density	_	_	
39-14	5334-5336	on	_	_	
39-15	5337-5340	the	_	_	
39-16	5341-5350	substrate	_	_	
39-17	5350-5351	.	_	_	

#Text=The silicon oxide surface layer of the typical nanofiber substrates is quite hydrophilic in its native state.
40-1	5352-5355	The	_	_	
40-2	5356-5363	silicon	_	_	
40-3	5364-5369	oxide	_	_	
40-4	5370-5377	surface	_	_	
40-5	5378-5383	layer	_	_	
40-6	5384-5386	of	_	_	
40-7	5387-5390	the	_	_	
40-8	5391-5398	typical	_	_	
40-9	5399-5408	nanofiber	_	_	
40-10	5409-5419	substrates	_	_	
40-11	5420-5422	is	_	_	
40-12	5423-5428	quite	_	_	
40-13	5429-5440	hydrophilic	_	_	
40-14	5441-5443	in	_	_	
40-15	5444-5447	its	_	_	
40-16	5448-5454	native	_	_	
40-17	5455-5460	state	_	_	
40-18	5460-5461	.	_	_	

#Text=Water readily wets the surface and spreads out evenly.
41-1	5462-5467	Water	_	_	
41-2	5468-5475	readily	_	_	
41-3	5476-5480	wets	_	_	
41-4	5481-5484	the	_	_	
41-5	5485-5492	surface	_	_	
41-6	5493-5496	and	_	_	
41-7	5497-5504	spreads	_	_	
41-8	5505-5508	out	_	_	
41-9	5509-5515	evenly	_	_	
41-10	5515-5516	.	_	_	

#Text=This is partially due to the wicking properties of the surface.
42-1	5517-5521	This	_	_	
42-2	5522-5524	is	_	_	
42-3	5525-5534	partially	_	_	
42-4	5535-5538	due	_	_	
42-5	5539-5541	to	_	_	
42-6	5542-5545	the	_	_	
42-7	5546-5553	wicking	_	_	
42-8	5554-5564	properties	_	_	
42-9	5565-5567	of	_	_	
42-10	5568-5571	the	_	_	
42-11	5572-5579	surface	_	_	
42-12	5579-5580	.	_	_	

#Text=Functionalization of the surface is facilitated by the layer of native oxide that forms on the surface of the wires.
43-1	5581-5598	Functionalization	_	_	
43-2	5599-5601	of	_	_	
43-3	5602-5605	the	_	_	
43-4	5606-5613	surface	_	_	
43-5	5614-5616	is	_	_	
43-6	5617-5628	facilitated	_	_	
43-7	5629-5631	by	_	_	
43-8	5632-5635	the	_	_	
43-9	5636-5641	layer	_	_	
43-10	5642-5644	of	_	_	
43-11	5645-5651	native	_	_	
43-12	5652-5657	oxide	_	_	
43-13	5658-5662	that	_	_	
43-14	5663-5668	forms	_	_	
43-15	5669-5671	on	_	_	
43-16	5672-5675	the	_	_	
43-17	5676-5683	surface	_	_	
43-18	5684-5686	of	_	_	
43-19	5687-5690	the	_	_	
43-20	5691-5696	wires	_	_	
43-21	5696-5697	.	_	_	

#Text=This layer of SiO.sub.2 can be modified using standard silane chemistry to present functional groups on the outside of the wire.
44-1	5698-5702	This	_	_	
44-2	5703-5708	layer	_	_	
44-3	5709-5711	of	_	_	
44-4	5712-5719	SiO.sub	_	_	
44-5	5719-5721	.2	_	_	
44-6	5722-5725	can	_	_	
44-7	5726-5728	be	_	_	
44-8	5729-5737	modified	_	_	
44-9	5738-5743	using	_	_	
44-10	5744-5752	standard	_	_	
44-11	5753-5759	silane	_	_	
44-12	5760-5769	chemistry	_	_	
44-13	5770-5772	to	_	_	
44-14	5773-5780	present	_	_	
44-15	5781-5791	functional	_	_	
44-16	5792-5798	groups	_	_	
44-17	5799-5801	on	_	_	
44-18	5802-5805	the	_	_	
44-19	5806-5813	outside	_	_	
44-20	5814-5816	of	_	_	
44-21	5817-5820	the	_	_	
44-22	5821-5825	wire	_	_	
44-23	5825-5826	.	_	_	

#Text=For example the surface can be treated with gaseous hexamethyldisilane (HMDS) to make it extremely hydrophobic.
45-1	5827-5830	For	_	_	
45-2	5831-5838	example	_	_	
45-3	5839-5842	the	_	_	
45-4	5843-5850	surface	_	_	
45-5	5851-5854	can	_	_	
45-6	5855-5857	be	_	_	
45-7	5858-5865	treated	_	_	
45-8	5866-5870	with	_	_	
45-9	5871-5878	gaseous	_	_	
45-10	5879-5897	hexamethyldisilane	_	_	
45-11	5898-5899	(	_	_	
45-12	5899-5903	HMDS	_	_	
45-13	5903-5904	)	_	_	
45-14	5905-5907	to	_	_	
45-15	5908-5912	make	_	_	
45-16	5913-5915	it	_	_	
45-17	5916-5925	extremely	_	_	
45-18	5926-5937	hydrophobic	_	_	
45-19	5937-5938	.	_	_	

#Text=See, above.
46-1	5939-5942	See	_	_	
46-2	5942-5943	,	_	_	
46-3	5944-5949	above	_	_	
46-4	5949-5950	.	_	_	

#Text=In addition, it is possible to use multi-component nanofiber surfaces to tailor a medical device for a particular application.
47-1	5951-5953	In	_	_	
47-2	5954-5962	addition	_	_	
47-3	5962-5963	,	_	_	
47-4	5964-5966	it	_	_	
47-5	5967-5969	is	_	_	
47-6	5970-5978	possible	_	_	
47-7	5979-5981	to	_	_	
47-8	5982-5985	use	_	_	
47-9	5986-6001	multi-component	_	_	
47-10	6002-6011	nanofiber	_	_	
47-11	6012-6020	surfaces	_	_	
47-12	6021-6023	to	_	_	
47-13	6024-6030	tailor	_	_	
47-14	6031-6032	a	_	_	
47-15	6033-6040	medical	_	_	
47-16	6041-6047	device	_	_	
47-17	6048-6051	for	_	_	
47-18	6052-6053	a	_	_	
47-19	6054-6064	particular	_	_	
47-20	6065-6076	application	_	_	
47-21	6076-6077	.	_	_	

#Text=For example, a hydrophobic (or hydrophilic) nanofiber surface which resists cellular attachment (and thus biofilm formation) as described above can also be specifically tailored to allow one or more specific types of cells such as endothelial cells, osteoblasts, etc. to grow on some (or all) portions of the surface (e.g., where cellular integration and proliferation is needed), e.g., by modifying the hydrophobic (or hydrophilic) nanofiber surface with functional groups (e.g., fibronectin, collagen, RGD containing peptides, extracellular matrix proteins, chemoattracts, and other cell binding motifs)--which promote cellular attachment and integration.
48-1	6078-6081	For	_	_	
48-2	6082-6089	example	_	_	
48-3	6089-6090	,	_	_	
48-4	6091-6092	a	_	_	
48-5	6093-6104	hydrophobic	_	_	
48-6	6105-6106	(	_	_	
48-7	6106-6108	or	_	_	
48-8	6109-6120	hydrophilic	_	_	
48-9	6120-6121	)	_	_	
48-10	6122-6131	nanofiber	_	_	
48-11	6132-6139	surface	_	_	
48-12	6140-6145	which	_	_	
48-13	6146-6153	resists	_	_	
48-14	6154-6162	cellular	_	_	
48-15	6163-6173	attachment	_	_	
48-16	6174-6175	(	_	_	
48-17	6175-6178	and	_	_	
48-18	6179-6183	thus	_	_	
48-19	6184-6191	biofilm	_	_	
48-20	6192-6201	formation	_	_	
48-21	6201-6202	)	_	_	
48-22	6203-6205	as	_	_	
48-23	6206-6215	described	_	_	
48-24	6216-6221	above	_	_	
48-25	6222-6225	can	_	_	
48-26	6226-6230	also	_	_	
48-27	6231-6233	be	_	_	
48-28	6234-6246	specifically	_	_	
48-29	6247-6255	tailored	_	_	
48-30	6256-6258	to	_	_	
48-31	6259-6264	allow	_	_	
48-32	6265-6268	one	_	_	
48-33	6269-6271	or	_	_	
48-34	6272-6276	more	_	_	
48-35	6277-6285	specific	_	_	
48-36	6286-6291	types	_	_	
48-37	6292-6294	of	_	_	
48-38	6295-6300	cells	_	_	
48-39	6301-6305	such	_	_	
48-40	6306-6308	as	_	_	
48-41	6309-6320	endothelial	_	_	
48-42	6321-6326	cells	_	_	
48-43	6326-6327	,	_	_	
48-44	6328-6339	osteoblasts	_	_	
48-45	6339-6340	,	_	_	
48-46	6341-6344	etc	_	_	
48-47	6344-6345	.	_	_	
48-48	6346-6348	to	_	_	
48-49	6349-6353	grow	_	_	
48-50	6354-6356	on	_	_	
48-51	6357-6361	some	_	_	
48-52	6362-6363	(	_	_	
48-53	6363-6365	or	_	_	
48-54	6366-6369	all	_	_	
48-55	6369-6370	)	_	_	
48-56	6371-6379	portions	_	_	
48-57	6380-6382	of	_	_	
48-58	6383-6386	the	_	_	
48-59	6387-6394	surface	_	_	
48-60	6395-6396	(	_	_	
48-61	6396-6399	e.g	_	_	
48-62	6399-6400	.	_	_	
48-63	6400-6401	,	_	_	
48-64	6402-6407	where	_	_	
48-65	6408-6416	cellular	_	_	
48-66	6417-6428	integration	_	_	
48-67	6429-6432	and	_	_	
48-68	6433-6446	proliferation	_	_	
48-69	6447-6449	is	_	_	
48-70	6450-6456	needed	_	_	
48-71	6456-6457	)	_	_	
48-72	6457-6458	,	_	_	
48-73	6459-6462	e.g	_	_	
48-74	6462-6463	.	_	_	
48-75	6463-6464	,	_	_	
48-76	6465-6467	by	_	_	
48-77	6468-6477	modifying	_	_	
48-78	6478-6481	the	_	_	
48-79	6482-6493	hydrophobic	_	_	
48-80	6494-6495	(	_	_	
48-81	6495-6497	or	_	_	
48-82	6498-6509	hydrophilic	_	_	
48-83	6509-6510	)	_	_	
48-84	6511-6520	nanofiber	_	_	
48-85	6521-6528	surface	_	_	
48-86	6529-6533	with	_	_	
48-87	6534-6544	functional	_	_	
48-88	6545-6551	groups	_	_	
48-89	6552-6553	(	_	_	
48-90	6553-6556	e.g	_	_	
48-91	6556-6557	.	_	_	
48-92	6557-6558	,	_	_	
48-93	6559-6570	fibronectin	_	_	
48-94	6570-6571	,	_	_	
48-95	6572-6580	collagen	_	_	
48-96	6580-6581	,	_	_	
48-97	6582-6585	RGD	_	_	
48-98	6586-6596	containing	_	_	
48-99	6597-6605	peptides	_	_	
48-100	6605-6606	,	_	_	
48-101	6607-6620	extracellular	_	_	
48-102	6621-6627	matrix	_	_	
48-103	6628-6636	proteins	_	_	
48-104	6636-6637	,	_	_	
48-105	6638-6651	chemoattracts	_	_	
48-106	6651-6652	,	_	_	
48-107	6653-6656	and	_	_	
48-108	6657-6662	other	_	_	
48-109	6663-6667	cell	_	_	
48-110	6668-6675	binding	_	_	
48-111	6676-6682	motifs	_	_	
48-112	6682-6683	)	_	_	
48-113	6683-6684	-	_	_	
48-114	6684-6685	-	_	_	
48-115	6685-6690	which	_	_	
48-116	6691-6698	promote	_	_	
48-117	6699-6707	cellular	_	_	
48-118	6708-6718	attachment	_	_	
48-119	6719-6722	and	_	_	
48-120	6723-6734	integration	_	_	
48-121	6734-6735	.	_	_	

#Text=The hydrophobic layer may diminish over time as the desired cells integrate.
49-1	6736-6739	The	_	_	
49-2	6740-6751	hydrophobic	_	_	
49-3	6752-6757	layer	_	_	
49-4	6758-6761	may	_	_	
49-5	6762-6770	diminish	_	_	
49-6	6771-6775	over	_	_	
49-7	6776-6780	time	_	_	
49-8	6781-6783	as	_	_	
49-9	6784-6787	the	_	_	
49-10	6788-6795	desired	_	_	
49-11	6796-6801	cells	_	_	
49-12	6802-6811	integrate	_	_	
49-13	6811-6812	.	_	_	

#Text=Thus, medical devices such as catheters, implants and the like can be engineered to resist biofilm formation over portions of or their entire surface by rendering the nanofiber surface hydrophobic as described above and in co-pending U.S.
50-1	6813-6817	Thus	_	_	
50-2	6817-6818	,	_	_	
50-3	6819-6826	medical	_	_	
50-4	6827-6834	devices	_	_	
50-5	6835-6839	such	_	_	
50-6	6840-6842	as	_	_	
50-7	6843-6852	catheters	_	_	
50-8	6852-6853	,	_	_	
50-9	6854-6862	implants	_	_	
50-10	6863-6866	and	_	_	
50-11	6867-6870	the	_	_	
50-12	6871-6875	like	_	_	
50-13	6876-6879	can	_	_	
50-14	6880-6882	be	_	_	
50-15	6883-6893	engineered	_	_	
50-16	6894-6896	to	_	_	
50-17	6897-6903	resist	_	_	
50-18	6904-6911	biofilm	_	_	
50-19	6912-6921	formation	_	_	
50-20	6922-6926	over	_	_	
50-21	6927-6935	portions	_	_	
50-22	6936-6938	of	_	_	
50-23	6939-6941	or	_	_	
50-24	6942-6947	their	_	_	
50-25	6948-6954	entire	_	_	
50-26	6955-6962	surface	_	_	
50-27	6963-6965	by	_	_	
50-28	6966-6975	rendering	_	_	
50-29	6976-6979	the	_	_	
50-30	6980-6989	nanofiber	_	_	
50-31	6990-6997	surface	_	_	
50-32	6998-7009	hydrophobic	_	_	
50-33	7010-7012	as	_	_	
50-34	7013-7022	described	_	_	
50-35	7023-7028	above	_	_	
50-36	7029-7032	and	_	_	
50-37	7033-7035	in	_	_	
50-38	7036-7046	co-pending	_	_	
50-39	7047-7050	U.S	_	_	
50-40	7050-7051	.	_	_	

#Text=Ser.
51-1	7052-7055	Ser	_	_	
51-2	7055-7056	.	_	_	

#Text=No. 10/833,944, filed Apr. 27, 2004, the entire contents of which are incorporated by reference herein, and then the surface coverage of one or more functional groups on the hydrophobic surface can be precisely controlled to encourage cellular attachment in specific areas where tissue integration is most desirable (e.g., where grafting or bonding is to occur).
52-1	7057-7059	No	_	_	
52-2	7059-7060	.	_	_	
52-3	7061-7063	10	_	_	
52-4	7063-7064	/	_	_	
52-5	7064-7071	833,944	_	_	
52-6	7071-7072	,	_	_	
52-7	7073-7078	filed	_	_	
52-8	7079-7082	Apr	_	_	
52-9	7082-7083	.	_	_	
52-10	7084-7086	27	_	_	
52-11	7086-7087	,	_	_	
52-12	7088-7092	2004	_	_	
52-13	7092-7093	,	_	_	
52-14	7094-7097	the	_	_	
52-15	7098-7104	entire	_	_	
52-16	7105-7113	contents	_	_	
52-17	7114-7116	of	_	_	
52-18	7117-7122	which	_	_	
52-19	7123-7126	are	_	_	
52-20	7127-7139	incorporated	_	_	
52-21	7140-7142	by	_	_	
52-22	7143-7152	reference	_	_	
52-23	7153-7159	herein	_	_	
52-24	7159-7160	,	_	_	
52-25	7161-7164	and	_	_	
52-26	7165-7169	then	_	_	
52-27	7170-7173	the	_	_	
52-28	7174-7181	surface	_	_	
52-29	7182-7190	coverage	_	_	
52-30	7191-7193	of	_	_	
52-31	7194-7197	one	_	_	
52-32	7198-7200	or	_	_	
52-33	7201-7205	more	_	_	
52-34	7206-7216	functional	_	_	
52-35	7217-7223	groups	_	_	
52-36	7224-7226	on	_	_	
52-37	7227-7230	the	_	_	
52-38	7231-7242	hydrophobic	_	_	
52-39	7243-7250	surface	_	_	
52-40	7251-7254	can	_	_	
52-41	7255-7257	be	_	_	
52-42	7258-7267	precisely	_	_	
52-43	7268-7278	controlled	_	_	
52-44	7279-7281	to	_	_	
52-45	7282-7291	encourage	_	_	
52-46	7292-7300	cellular	_	_	
52-47	7301-7311	attachment	_	_	
52-48	7312-7314	in	_	_	
52-49	7315-7323	specific	_	_	
52-50	7324-7329	areas	_	_	
52-51	7330-7335	where	_	_	
52-52	7336-7342	tissue	_	_	
52-53	7343-7354	integration	_	_	
52-54	7355-7357	is	_	_	
52-55	7358-7362	most	_	_	
52-56	7363-7372	desirable	_	_	
52-57	7373-7374	(	_	_	
52-58	7374-7377	e.g	_	_	
52-59	7377-7378	.	_	_	
52-60	7378-7379	,	_	_	
52-61	7380-7385	where	_	_	
52-62	7386-7394	grafting	_	_	
52-63	7395-7397	or	_	_	
52-64	7398-7405	bonding	_	_	
52-65	7406-7408	is	_	_	
52-66	7409-7411	to	_	_	
52-67	7412-7417	occur	_	_	
52-68	7417-7418	)	_	_	
52-69	7418-7419	.	_	_	

#Text=Examples of multicomponent films are demonstrated and described, for example, in T.
53-1	7420-7428	Examples	_	_	
53-2	7429-7431	of	_	_	
53-3	7432-7446	multicomponent	_	_	
53-4	7447-7452	films	_	_	
53-5	7453-7456	are	_	_	
53-6	7457-7469	demonstrated	_	_	
53-7	7470-7473	and	_	_	
53-8	7474-7483	described	_	_	
53-9	7483-7484	,	_	_	
53-10	7485-7488	for	_	_	
53-11	7489-7496	example	_	_	
53-12	7496-7497	,	_	_	
53-13	7498-7500	in	_	_	
53-14	7501-7502	T	_	_	
53-15	7502-7503	.	_	_	

#Text=M.
54-1	7504-7505	M	_	_	
54-2	7505-7506	.	_	_	

#Text=Heme et al., Characterization of DNA Probes Immobilized on Gold Surfaces, J.
55-1	7507-7511	Heme	_	_	
55-2	7512-7514	et	_	_	
55-3	7515-7517	al	_	_	
55-4	7517-7518	.	_	_	
55-5	7518-7519	,	_	_	
55-6	7520-7536	Characterization	_	_	
55-7	7537-7539	of	_	_	
55-8	7540-7543	DNA	_	_	
55-9	7544-7550	Probes	_	_	
55-10	7551-7562	Immobilized	_	_	
55-11	7563-7565	on	_	_	
55-12	7566-7570	Gold	_	_	
55-13	7571-7579	Surfaces	_	_	
55-14	7579-7580	,	_	_	
55-15	7581-7582	J	_	_	
55-16	7582-7583	.	_	_	

#Text=Am.
56-1	7584-7586	Am	_	_	
56-2	7586-7587	.	_	_	

#Text=Chem.
57-1	7588-7592	Chem	_	_	
57-2	7592-7593	.	_	_	

#Text=Soc. 1997, 119, 8916-8920 (e.g., FIG. 4), the entire contents of which are incorporated by reference herein."
58-1	7594-7597	Soc	_	_	
58-2	7597-7598	.	_	_	
58-3	7599-7603	1997	_	_	
58-4	7603-7604	,	_	_	
58-5	7605-7608	119	_	_	
58-6	7608-7609	,	_	_	
58-7	7610-7614	8916	_	_	
58-8	7614-7615	-	_	_	
58-9	7615-7619	8920	_	_	
58-10	7620-7621	(	_	_	
58-11	7621-7624	e.g	_	_	
58-12	7624-7625	.	_	_	
58-13	7625-7626	,	_	_	
58-14	7627-7630	FIG	_	_	
58-15	7630-7631	.	_	_	
58-16	7632-7633	4	_	_	
58-17	7633-7634	)	_	_	
58-18	7634-7635	,	_	_	
58-19	7636-7639	the	_	_	
58-20	7640-7646	entire	_	_	
58-21	7647-7655	contents	_	_	
58-22	7656-7658	of	_	_	
58-23	7659-7664	which	_	_	
58-24	7665-7668	are	_	_	
58-25	7669-7681	incorporated	_	_	
58-26	7682-7684	by	_	_	
58-27	7685-7694	reference	_	_	
58-28	7695-7701	herein	_	_	
58-29	7701-7702	.	_	_	
58-30	7702-7703	"	_	_	
